TY  - GEN
AU  - Stemmler,H-J
AU  - Heinemann,V
TI  - [Oncology 2008]
SN  - 1439-4413
PY  - 2008///0625
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - Bevacizumab
KW  - Cetuximab
KW  - Combined Modality Therapy
KW  - Disease Progression
KW  - Epothilones
KW  - Humans
KW  - Lapatinib
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Neoplasms
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Panitumumab
KW  - Phenylurea Compounds
KW  - Prognosis
KW  - Pyridines
KW  - Quinazolines
KW  - Randomized Controlled Trials as Topic
KW  - Sorafenib
KW  - Survival Rate
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1055/s-2008-1081075
ER  -